CWM LLC increased its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 105.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 74,331 shares of the company's stock after acquiring an additional 38,196 shares during the quarter. CWM LLC's holdings in Bath & Body Works were worth $2,254,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of the company. Golden State Wealth Management LLC lifted its position in Bath & Body Works by 94.7% during the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock valued at $40,000 after purchasing an additional 642 shares during the last quarter. UMB Bank n.a. lifted its position in Bath & Body Works by 65.9% during the first quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock valued at $46,000 after purchasing an additional 596 shares during the last quarter. Ancora Advisors LLC bought a new stake in Bath & Body Works during the fourth quarter valued at approximately $67,000. TD Private Client Wealth LLC lifted its position in Bath & Body Works by 34.9% during the fourth quarter. TD Private Client Wealth LLC now owns 2,290 shares of the company's stock valued at $89,000 after purchasing an additional 593 shares during the last quarter. Finally, Quarry LP bought a new stake in shares of Bath & Body Works in the 4th quarter worth approximately $122,000. 95.14% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
BBWI has been the subject of several recent research reports. UBS Group boosted their price target on shares of Bath & Body Works from $32.00 to $36.00 and gave the stock a "neutral" rating in a research note on Tuesday, May 20th. The Goldman Sachs Group lowered their price target on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a research note on Friday, May 30th. Citigroup boosted their price target on shares of Bath & Body Works from $36.00 to $42.00 and gave the stock a "buy" rating in a research note on Tuesday, May 20th. Wells Fargo & Company boosted their price target on shares of Bath & Body Works from $40.00 to $44.00 and gave the stock an "overweight" rating in a research note on Wednesday, May 14th. Finally, Raymond James Financial lowered their price target on shares of Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating for the company in a research note on Thursday, April 17th. Four equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $42.00.
Get Our Latest Stock Analysis on Bath & Body Works
Bath & Body Works Price Performance
Bath & Body Works stock traded up $0.99 during mid-day trading on Monday, reaching $32.77. 1,830,160 shares of the company traded hands, compared to its average volume of 5,248,616. The firm's 50 day moving average price is $30.16 and its 200 day moving average price is $32.21. The firm has a market capitalization of $6.93 billion, a price-to-earnings ratio of 8.74, a P/E/G ratio of 1.07 and a beta of 1.72. Bath & Body Works, Inc. has a 52-week low of $24.94 and a 52-week high of $41.87.
Bath & Body Works (NYSE:BBWI - Get Free Report) last released its earnings results on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, topping analysts' consensus estimates of $0.47 by $0.02. The firm had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.42 billion. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. The company's revenue was up 2.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.38 EPS. On average, sell-side analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current year.
Bath & Body Works Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, June 20th. Stockholders of record on Friday, June 6th were given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.44%. The ex-dividend date of this dividend was Friday, June 6th. Bath & Body Works's dividend payout ratio is presently 21.33%.
About Bath & Body Works
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
See Also
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
